Esperion Therapeutics | ESPR - PE Price to Earnings


Esperion Therapeutics reported 129.79 in PE Price to Earnings for its fiscal quarter ending in December of 2024.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amarin 91.05 88.3 Jun/2023
Amgen 25.31 15.82 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Cipla 27.74 3.55 Dec/2025
CSL 16.16 9.59 Dec/2025
Daiichi Sankyo 20.73 1.74 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Grifols 11.2 1.08 Dec/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Merck 13.92 5.08 Dec/2025
Moderna 27.22 14.51 Jun/2023
Pfizer 14.48 5.18 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
United Therapeutics 17.32 1.62 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023